ZSAssoc in the house

Discussion in 'Boehringer Ingelheim' started by Anonymous, Jul 16, 2014 at 12:35 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    They are back to look at the best way to structure the field
     

  2. Anonymous

    Anonymous Guest

    Germany has the reigns. ZS is just their bitch!
     
  3. Anonymous

    Anonymous Guest

    Cause they did such a great job last time?
     
  4. Anonymous

    Anonymous Guest

    they need to have all teams mirror each other (spec/hosp/pcp) and then sleeve everyone on pcp. then pay everyone out the same which is on total dirt.
     
  5. Anonymous

    Anonymous Guest

    If ever there was a group that was paid for no results, it would be ZS. How can this company keep making the same mistakes and, further, BI pay them?
     
  6. Anonymous

    Anonymous Guest

    BI does that constantly. For example, CSC, HSE.
     
  7. Anonymous

    Anonymous Guest

    You need to educate yourself on the results of the Spiriva attainment numbers before and after CSC.
     
  8. Anonymous

    Anonymous Guest

    CSC is to market expansion as Greta is to market intelligence.
     
  9. Anonymous

    Anonymous Guest

    I don't know if we are that good, but thanks!
     
  10. Anonymous

    Anonymous Guest

    ZS may be more responsible than any other company for the state the pharma industry is currently in. The "Reach and Frequency" model they espoused everywhere ultimately led to reps being locked out of many offices/clinics/hospitals.
     
  11. Anonymous

    Anonymous Guest

    +1
     
  12. Anonymous

    Anonymous Guest

    ZS helps with deployment and call plans. Laros comes up with the crazy targeting and frequencies.
     
  13. Anonymous

    Anonymous Guest

    They must like the CSC's -they are going ready to expand that sales force part reps and part afib
     
  14. Anonymous

    Anonymous Guest

    What????
     
  15. Anonymous

    Anonymous Guest

    Hmm. Part rep and part a fib????
     
  16. Anonymous

    Anonymous Guest

    They will be part Spiriva and part pradaxa
     
  17. Anonymous

    Anonymous Guest

    they could can three out of four of your asses and still prove growth to the bottom line. useless
     
  18. Anonymous

    Anonymous Guest

    Sure they will. Because we have so many things in the pipeline for CV.
     
  19. Anonymous

    Anonymous Guest

    Clearly with what rolled through you have all been mistaken
     
  20. Anonymous

    Anonymous Guest

    ?